Albendazole Anthelmintic Drug Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23
SKU : PH3121
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Albendazole Anthelmintic Drug Market growth?
Albendazole Anthelmintic Drug Market is expected to grow at a CAGR of 6.5% during the forecast period (2024-2031)
Who are the key players in Albendazole Anthelmintic Drug Market?
Key players are GlaxoSmithKline, Fredun Pharmaceuticals Ltd, Sequent Scientific, Huazhong Pharmaceutical, Zhongjia Pharmaceutical, Jiangsu Qihui, Salius Pharma, Lasa Supergenerics Limited, K.A. Malle Pharmaceuticals, Supharma Chem, among others.
Related Reports
pharmaceuticals

Scabies Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Postpartum Hemorrhage Treatment Market Size, Share, Forecast and Outlook (2023-2030)

Published: 2023 September 25
Starting from

$4350

pharmaceuticals

Chronic Disease Management Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Shigella Infections Market Size, Share, Industry, Forecast and Demand (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Bloom Syndrome Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 15
Starting from

$4350

pharmaceuticals

Bacteremia Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 November 14
Starting from

$4350